Search for tag: "acc18"

ACC 2018: What are the takeaways of the ODYSSEY Outcomes Trial?

Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses the results the ODYSSEY trail looking at the PCSK9 inhibitor alirocumab in patients who had a prior acute coronary syndrome and were…

From  ConsultQD Live Admin 0 likes 15 plays

ACC 2018: Is Routine Use of Beta Blockers in Patients having Non Cardiac Surgery Beneficial?

Dr. Steve Nissen, Chairman of Cardiovascular Medicine, discusses a study (POISE) presented at ACC looking at patients provided beta blockers prophylactically before non-cardiac surgery. …

From  ConsultQD Live Admin 0 likes 22 plays